| Michelle M Bliss, CRNA | |
|
15190 Community Rd, Suite 230a, Gulfport, MS 39503-3485 | |
| (228) 831-0204 | |
| (228) 831-1868 |
| Full Name | Michelle M Bliss |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 16 Years |
| Location | 15190 Community Rd, Gulfport, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811159460 | NPI | - | NPPES |
| R866309 | Other | MS | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R866309 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Highland Community Hospital | Picayune, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Deep South Anesthesia, Inc | 4284897612 | 5 |
| Hattiesburg Clinic, Pa | 5193706794 | 489 |
| Anesthesiology Affiliates Llc | 6800936162 | 49 |
News Archive
Today's headlines include a number of reports about how Medicare and other health policy issues are playing important roles on the campaign trail.
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the introduction of nCounter Vantage, a portfolio of assays that power 3D Biology™ experiments in cancer research, including immuno-oncology.
A man in St. Louis and a woman in New Hampshire have received the first kidney transplants made possible through a new national program of the Organ Procurement and Transplantation Network that uses a Carnegie Mellon University computer algorithm to match transplant candidates with living donors.
Helsinn Group and Eisai Inc. announced today that Helsinn has commenced a multi-centered Phase III clinical study program investigating the Netupitant/Palonosetron (300mg/0.50mg) oral fixed-dose combination for the prevention of chemotherapy-induced nausea and vomiting.
› Verified 4 days ago
| Entity Name | Hattiesburg Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740213446 PECOS PAC ID: 5193706794 Enrollment ID: O20040528000685 |
News Archive
Today's headlines include a number of reports about how Medicare and other health policy issues are playing important roles on the campaign trail.
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the introduction of nCounter Vantage, a portfolio of assays that power 3D Biology™ experiments in cancer research, including immuno-oncology.
A man in St. Louis and a woman in New Hampshire have received the first kidney transplants made possible through a new national program of the Organ Procurement and Transplantation Network that uses a Carnegie Mellon University computer algorithm to match transplant candidates with living donors.
Helsinn Group and Eisai Inc. announced today that Helsinn has commenced a multi-centered Phase III clinical study program investigating the Netupitant/Palonosetron (300mg/0.50mg) oral fixed-dose combination for the prevention of chemotherapy-induced nausea and vomiting.
› Verified 4 days ago
| Entity Name | Deep South Anesthesia, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164738712 PECOS PAC ID: 4284897612 Enrollment ID: O20120523000317 |
News Archive
Today's headlines include a number of reports about how Medicare and other health policy issues are playing important roles on the campaign trail.
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the introduction of nCounter Vantage, a portfolio of assays that power 3D Biology™ experiments in cancer research, including immuno-oncology.
A man in St. Louis and a woman in New Hampshire have received the first kidney transplants made possible through a new national program of the Organ Procurement and Transplantation Network that uses a Carnegie Mellon University computer algorithm to match transplant candidates with living donors.
Helsinn Group and Eisai Inc. announced today that Helsinn has commenced a multi-centered Phase III clinical study program investigating the Netupitant/Palonosetron (300mg/0.50mg) oral fixed-dose combination for the prevention of chemotherapy-induced nausea and vomiting.
› Verified 4 days ago
| Entity Name | Lifelinc Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801021464 PECOS PAC ID: 0941347447 Enrollment ID: O20130522000277 |
News Archive
Today's headlines include a number of reports about how Medicare and other health policy issues are playing important roles on the campaign trail.
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the introduction of nCounter Vantage, a portfolio of assays that power 3D Biology™ experiments in cancer research, including immuno-oncology.
A man in St. Louis and a woman in New Hampshire have received the first kidney transplants made possible through a new national program of the Organ Procurement and Transplantation Network that uses a Carnegie Mellon University computer algorithm to match transplant candidates with living donors.
Helsinn Group and Eisai Inc. announced today that Helsinn has commenced a multi-centered Phase III clinical study program investigating the Netupitant/Palonosetron (300mg/0.50mg) oral fixed-dose combination for the prevention of chemotherapy-induced nausea and vomiting.
› Verified 4 days ago
| Entity Name | Youngs Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922178599 PECOS PAC ID: 2163524992 Enrollment ID: O20141015000028 |
News Archive
Today's headlines include a number of reports about how Medicare and other health policy issues are playing important roles on the campaign trail.
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the introduction of nCounter Vantage, a portfolio of assays that power 3D Biology™ experiments in cancer research, including immuno-oncology.
A man in St. Louis and a woman in New Hampshire have received the first kidney transplants made possible through a new national program of the Organ Procurement and Transplantation Network that uses a Carnegie Mellon University computer algorithm to match transplant candidates with living donors.
Helsinn Group and Eisai Inc. announced today that Helsinn has commenced a multi-centered Phase III clinical study program investigating the Netupitant/Palonosetron (300mg/0.50mg) oral fixed-dose combination for the prevention of chemotherapy-induced nausea and vomiting.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle M Bliss, CRNA 15190 Community Rd, Suite 230a, Gulfport, MS 39503-3485 Ph: (228) 831-0204 | Michelle M Bliss, CRNA 15190 Community Rd, Suite 230a, Gulfport, MS 39503-3485 Ph: (228) 831-0204 |
News Archive
Today's headlines include a number of reports about how Medicare and other health policy issues are playing important roles on the campaign trail.
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the introduction of nCounter Vantage, a portfolio of assays that power 3D Biology™ experiments in cancer research, including immuno-oncology.
A man in St. Louis and a woman in New Hampshire have received the first kidney transplants made possible through a new national program of the Organ Procurement and Transplantation Network that uses a Carnegie Mellon University computer algorithm to match transplant candidates with living donors.
Helsinn Group and Eisai Inc. announced today that Helsinn has commenced a multi-centered Phase III clinical study program investigating the Netupitant/Palonosetron (300mg/0.50mg) oral fixed-dose combination for the prevention of chemotherapy-induced nausea and vomiting.
› Verified 4 days ago
Kathryn Pittman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 15200 Community Rd, Gulfport, MS 39503 Phone: 228-575-7000 | |
Jason Wells, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-865-3281 Fax: 228-867-5117 | |
Victor P Polito, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 15190 Community Rd, Suite 230a, Gulfport, MS 39503 Phone: 228-831-0204 Fax: 228-831-1868 | |
Glen Deitrick, C.R.N.A Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 15190 Community Rd, Suite 230a, Gulfport, MS 39503 Phone: 228-831-0204 Fax: 228-831-1868 | |
Glen Michael Cavalier, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 15200 Community Rd, Gulfport, MS 39503 Phone: 228-575-7000 | |
Julie K Klester, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 15190 Community Rd, Suite 230a, Gulfport, MS 39503 Phone: 228-831-0204 Fax: 228-831-1868 | |
Trinh Thu Weatherly, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-867-4000 |